SARS-CoV-2 Antibody ELISAs for Hemostasis Research

Posted: July 15, 2021

It’s Not Just Support. It’s Solutions.

SARS-CoV-2 Antibody ELISA Kits and Mechanistic Biomarker Assays for COVID-19 Related Research

DiaPharma is your trusted supplier of high quality assays for your COVID-19 related research

Is there anything COVID-19 doesn’t touch? We know SARS CoV-2 impacts various hemostasis parameters. Research is ongoing to gain a better understanding of the mechanisms and pathways involved in COVID-19.

Beyond specialty hemostasis assays, DiaPharma supplies ELISA kits to test for SARS CoV-2 IgG and IgM Antibodies. These assays can be used to help differentiate the possible causes of antibodies against SAR-CoV-2 in test samples, whether from prior infection, vaccination, or both.

With quantitative and qualitative ELISAs to detect antibodies to Nucleocapsid or Spike protein, DiaPharma has many options to fit your assay needs.

Explore assays for SARS-CoV-2 Antibodies, Thromboinflammation, Coagulation, Fibrinolysis, Complement, Platelet Function, and Organ Injury (apoptosis and necrosis).

It’s Not Just Support. It’s Solutions.

Over 20 years of scientific expertise, with support just a call or click away.

DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069

Technical Support: 1.800.447.3846

ML-00-00836Rev02